Browsing Category

63286 posts
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications

Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications

ROCKVILLE, Md. and SUZHOU, China, Dec. 18, 2023 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX:…
FITTING MONSTER Eyewear Virtual Try-on service begins in Japanese market

FITTING MONSTER Eyewear Virtual Try-on service begins in Japanese market

SEOUL, South Korea, Dec. 18, 2023 /PRNewswire/ —  FITTING MONSTER, a company…
The launch of Prophe, a global distribution platform for app books

The launch of Prophe, a global distribution platform for app books

SEOUL, South Korea, Dec. 18, 2023 /PRNewswire/ — Appmedia Inc. launched its…
Cyber Threat Intelligence "Criminal IP": Technology partnerships with global enterprises with expansion into the Japanese market

Cyber Threat Intelligence "Criminal IP": Technology partnerships with global enterprises with expansion into the Japanese market

SEOUL, South Korea, Dec. 18, 2023 /PRNewswire/ — AI SPERA, a Cyber Threat Intelligence…
Paradise City Successfully Wraps Up Global Campaign Hosting Asian Influencers

Paradise City Successfully Wraps Up Global Campaign Hosting Asian Influencers

Ultimate K-Culture Experience at Paradise City"All about K, this is it. Paradise City!"…
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

SHANGHAI, Dec. 17, 2023 /PRNewswire/ — YolTech Therapeutics today announced that the…